These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Premature mortality due to cardiovascular disease in hypopituitarism. Rosén T; Bengtsson BA Lancet; 1990 Aug; 336(8710):285-8. PubMed ID: 1973979 [TBL] [Abstract][Full Text] [Related]
6. [Impact of hormonal deficit and cardiovascular risk factors on life expectancy in hypopituitarism]. Ricart W; Fernández-Real JM Med Clin (Barc); 2003 May; 120(16):630-7. PubMed ID: 12732130 [No Abstract] [Full Text] [Related]
7. High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism. Krzyzanowska K; Schnack C; Mittermayer F; Kopp HP; Hofer M; Kann T; Schernthaner G Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):430-4. PubMed ID: 16151976 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficiency in adults: a new indication for recombinant human growth hormone. Bengtsson BA J Intern Med; 1996 Apr; 239(4):283-6. PubMed ID: 8774381 [No Abstract] [Full Text] [Related]
11. Growth hormone deficiency in adults: to treat or not to treat. Hoffman DM; Ho KK Aust N Z J Med; 1999 Jun; 29(3):342-9. PubMed ID: 10868497 [No Abstract] [Full Text] [Related]
16. Changes in skeletal muscle after discontinuation of growth hormone treatment in young adults with hypopituitarism. Rutherford OM; Jones DA; Round JM; Preece MA Acta Paediatr Scand Suppl; 1989; 356():61-3; discussion 64, 73-4. PubMed ID: 2816359 [TBL] [Abstract][Full Text] [Related]
17. Metabolic changes and vascular risk factors in hypopituitarism. Johnston DG; Beshyah SA; Markussis V; Shahi M; Sharp PS; Foale RA; Skinner EM Horm Res; 1992; 38 Suppl 1():68-72. PubMed ID: 1295816 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of adult growth hormone deficiency. Prevalence, incidence, mortality and morbidity. Erfurth EM Front Horm Res; 2005; 33():21-32. PubMed ID: 16166753 [No Abstract] [Full Text] [Related]
19. Cardiovascular outcomes and conventional risk factors in non-diabetic adult patients with GH deficiency: A long-term retrospective cohort study. de Gregorio C; Andò G; Cannavò S; Cotta OR; Trio O; Cusmà Piccione M; Trimarchi F; Curtò L Eur J Intern Med; 2015 Dec; 26(10):813-8. PubMed ID: 26548714 [TBL] [Abstract][Full Text] [Related]
20. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Wüster C; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; J Bone Miner Res; 2001 Feb; 16(2):398-405. PubMed ID: 11204440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]